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Abstract 
 
Introduction:  Meta-analysis of study-level data is now a common tool for gathering 
insights within a research field.  “Recurrent events” characterises the data for a range 
of outcomes that may be encountered in clinical practice.  Methods to conduct meta-
analyses using study-level data from investigations where recurrent events are of 
interest are yet to be specifically developed.  This study seeks to examine whether 
existing study-level data meta-analysis approaches can be used to produce unbiased 
and precise effect estimates relative to meta-analyses conducted using patient level 
data where a recurrent event is the outcome of interest. 
 
Method:  Data from two studies focussing on the prevention of falls in the hospital 
setting (n=1838 total) was divided into the three hospital sites from which they were 
collected.  Outcome data was considered as recurrent event survival data, single event 
survival data, count data, rate data and binary data.  Analysis approaches including 
Andersen-Gill recurrent events survival analysis, Cox single event survival analysis, 
negative binomial regression, bootstrap resampling, relative risk and modified relative 
risk, and logistic regression were investigated.   
 
Results:  Andersen-Gill, negative binomial, bootstrap resampling and modified 
relative risk analysis approaches produced congruous point estimates of effect, though 
modified relative risk analysis produced 95% confidence intervals much narrower 
than other approaches.  Pooling data using these analysis approaches resulted in 
biased and imprecise effect estimates when using study-level data as opposed to 
patient-level data. 
 
Conclusion:  Meta-analysis using study-level data may produce unbiased and precise 
estimates of effect where statistical heterogeneity is not present, where other forms of 
heterogeneity are not present, and where data has been presented using either 
Andersen-Gill or negative binomial regression approaches.  When these conditions 
are not met it is recommended (?preferable) that researchers present results from 





Meta-analysis is an increasingly popular tool that can be used to investigate a number 
of issues including the strength of association between a risk factor and a disease, the 
accuracy of a screening instrument, or the efficacy of a treatment protocol.  The 
importance of this tool is highlighted by the eminence afforded to results generated 
using this approach.  When evaluating the efficacy of treatment protocols, some rating 
scales of evidence for clinical practice place the results of meta-analysis above that 
gleaned from individual randomised controlled trials,1 though other scales place 
results from high quality individual randomised trials on par with meta-analyses.2, 3 
Meta-analysis has not been without its critics and several strategies for improving the 
validity of findings derived from meta-analysis have previously been suggested.4 
 
Two levels of data can be used to conduct a meta-analysis.  More commonly, 
researchers use summative data from published literature (meta-analysis literature – 
MAL) to construct their pooled estimates of effect.  Less frequent are investigations 
that utilise individual patient level-data (meta-analysis patient – MAP).  Key reasons 
for MAL to be used preferentially to MAP include the difficulty in attaining 
individual patient level data with which to conduct MAP, and the considerably greater 
time and resource required to conduct MAP.5  However, MAP is the gold standard 
approach to meta-analysis6 making it the approach of choice where either a MAL or 
MAP could feasibly be conducted,  
 
Previous authors have sought to compare the results of MAP and MAL within a 
particular field and in simulation studies.  Several have found discordance between 
the two approaches though this has frequently been attributable to different sets of 
patients and / or studies being included.7  Another investigation of the risk of 
epithelial ovarian cancer from use of the oral contraceptive pill found these 
approaches to be concordant, though had to exclude studies identified as being 
sources of heterogeneity before being able to do so.5  Other investigators 
demonstrated that MAP was mathematically identical to MAL for a model comparing 
multiple treatments to a control for a continuous outcome under the assumptions of 
fixed effects.8  If MAL is able to produce equivalent results to MAP, then the time 
and resource savings associated with this approach would clearly make MAL the 
approach of preference.  However, it also follows that if MAP is unable to be 
undertaken and MAL does not produce equivalent results to MAP, then it is 
questionable as to whether a meta-analysis should be pursued at all. 
 
One area where it is unclear whether MAL produces equivalent results to MAP is the 
study of diseases that may recur (e.g. episodes of cancer, urinary tract infections, 
epileptic seizures), particularly where the rate of disease occurrence is of primary 
importance.  One field where this is certainly the case is the prevention of accidental 
falls in hospitals.  It has previously been argued that the rate of falls (number of falls 
by a patient divided by the length of time they are observed) is of greater importance 
in this field than the proportion of patients who experience one or more falls, or even 
the sum total number of falls because of the varied total length of  the observation 
period for the participants in studies conducted in this field.  The time period in falls 
studies is a natural variation due to variations in each patient’s length of stay in 
hospital.  An added contextual factor in this field is that this style of data can be 
handled in several different ways and that a range of analysis approaches could 
potentially be used..  For example, in three recent randomised trials of targeted, 
multifactorial intervention programs, falls rate data has been considered as simple rate 
data (number of events divided by observation period) analysed using an adaptation of 
the relative risk calculation in one,10 and by XXX in another, and recurrent events 
survival data in another.11 This ‘statistical analysis approach’ heterogeneity may 
further threaten the validity of a MAL in this field.   
 
In this study, we are concerned with determining whether a MAL, for evaluation of 
either risk factors or interventions, is able to be validly undertaken within a field 
where the primary outcome of interest is the rate of a disease that can recur.  We first 
use a MAP approach to compare the findings of a range of analysis approaches to a 
gold standard for considering this style of data (aim 1).  We argue that if an approach 
produces biased or imprecise effect size estimates using a MAP approach, then a 
MAL using this approach will also produce biased or imprecise effect size estimates 
and will be unsuitable for practical use.  Second, we consider whether a MAL using a 
uniform approach to analysis of individual studies produces a precise and unbiased 
pooled effect estimate as that derived from a MAP using the same analysis approach 
(aim ii).  Third we consider what the differential effect on a pooled effect estimate 
would be if a MAL was attempted using study-level data comprising heterogenous 





Meta-analysis (both MAL and MAP) utilising prospectively collected falls data from 
two large randomised controlled trials of falls prevention interventions conducted 
across three hospital sites. 
 
Participants and setting: 
The first trial, conducted between 2002 and 2003 took place on three subacute 
rehabilitation wards at the Peter James Centre, Melbourne, Australia.  This study had 
n=626 participants and further details of this study have been published elsewhere.11  
The second, conducted between 2008 and 2009 took place on three geriatric 
assessment and rehabilitation wards, two acute orthopaedic wards, and one acute 
medicine / respiratory ward at the Princess Alexandra Hospital, Brisbane, Australia, 
and one medical and one surgical ward of the Swan Districts Hospital, Perth, 
Australia. This study had n=1206 participants in total, however data from n=1202 was 
used in this analysis (n=350 from Swan Districts Hospital, Perth, n=852 from Princess 
Alexandra Hospital, Brisbane) due to outliers still remaining in the study at the time 




The primary outcome measure in both of these studies was in-hospital falls.  In both 
studies, falls data was collated using local hospital incident reporting systems along 
with individual patient medical record review.  In the first study staff were provided 
with a standardised definition of a fall.11 In the second study, staff were provided with 
video-based training in how to apply a standardised definition of a fall,13 and falls data 
was additionally captured using weekly patient interview with a research assistant 
blinded to group allocation. 
 
Three independent variables were selected for examination in this study; participant 
gender, age, and admission diagnosis of stroke versus ‘not stroke’.  The median age of 
participants was 78 years, so this variable was converted to a dummy variable of 
young (<78 years) versus old (>78 years).  These three dichotomous variables were 
specifically selected on the basis of one having variable relationships with the raw 
number of falls and length of stay in hospital.  Participant gender had a strong 
relationship with falls but not patient length of stay in hospital.  Participant admission 
diagnosis of stroke had a strong relationship with both falls and length of stay in 




In addressing this aim we considered a range of analysis approaches that a researcher 
might encounter when attempting a meta-analysis in this field and analysis approaches 
that they could potentially encounter.  A description of each approach and justification 
for selection is presented (table 1). 
 
A MAP was undertaken for each approach with the combined dataset for the exposure 
variable to examine the relative bias and precision each approach had relative to the 
Andersen-Gill version of Cox semi-parametric survival analysis for recurrent events 
and negative binomial regression approaches.  Previous authors have advocated use of 
the Andersen-Gill approach for recurrent events data,14 while others have advocated 
use of negative binomial regression approach ahead of the Andersen-Gill survival 
approach due to the ease of computation of the former and the risk of violating the 
proportional hazards assumption in the latter.15  Thus we also checked the assumption 
of proportional hazards for each of the predictor variables (both visually and using the 




Analysis approaches identified from aim i) to produce relatively unbiased estimates of 
treatment effect from MAP were then used in MAL for each of the exposure 
variables.  The combined dataset was broken down into three separate studies 
according to site of data collection (Melbourne: n=626, Brisbane: n=852, Perth, 
n=350).  The Generic Inverse Variance Method was used in each case for undertaking 
the MAL.  Application of the Generic Inverse Variance Method requires two numbers 
from each study: an effect estimate and its standard error. The effect estimate 
summarises the treatment effect in a clinical trial or epidemiologic investigation (for 
example, an odds ratio or hazard ratio).  The standard error summarises the precision 
of the effect estimate.  The Generic Inverse Variance Method is available in the 
statistical program RevMan (version 5).  As the data analysis approaches considered 
in this study are ratios, using the Generic Inverse Variance Method required data to be 
entered as natural logarithms of the effect estimate (e.g. the natural logarithm of the 
hazard ratio) and standard errors of the natural logarithm of the effect estimate. 
Standard errors of the natural logarithm of the effect estimate were calculated using 
the difference between the natural logarithms of the upper and lower 95% confidence 
limits divided by 3.92 (a 95% confidence interval is 3.92 standard errors wide).  Both 
fixed and random effects analyses were undertaken, however results for the fixed 
effect analysis were only presented when I2=0.  
 
In addition to Generic Inverse Variance Method analyses, a “dichotomous data” MAL 
approach was employed entering the number of falls in the exposed and unexposed 
groups as the “events” for these groups, and the amount of participant observed time 
in the exposed and unexposed groups as the “total number of patients” data for these 
groups (Rate 5).  Days were used as the unit of measure of time.  A “Peto - observed 
minus expected” analysis was also considered for the pooling of survival analysis 
(first event) data.  This approach can only be used for this type of analysis, and 
requires effect sizes to be close to 1.0, and even numbers in the groups being 
compared to produced unbiased results.17  However this approach was not considered 
further as these three criteria were unlikely to be met in this field.   
  
Aim iii) A strength of the Generic Inverse Variance Method is that it can be employed 
in fields where results have been analysed and presented using a variety of 
approaches.  This approach weights the results of each study using the inverse of the 
variance of the effect estimate.  Therefore, the standard errors derived from the three 
separate site analyses for each exposure variable were contrasted to determine which 
approach would most strongly influence the MAL results.  Only the analysis 
approaches retained for examination in aim ii) were examined in aim iii). 
 
Estimates of effect size were calculated using STATA I/C version 10.0.  MAL were 




The distribution of exposure, outcome and study observation period variables for the 
combined sample and each individual site are presented (table 2).     
 
Aim i)  The results of the MAP for each of the analysis approaches examined are 
presented (figure 1).  It is apparent across all three exposure variables that the 
“Survival 1” Andersen-Gill recurrent events survival analysis, the “Count” negative 
binomial regression, the “Rate 1 & 2” bootstrap simulation approaches to calculating 
a relative rate, and the “Rate 3” relative rate calculation using the modified relative 
risk formula (days as unit of time measure) produced congruous point estimates of 
effect.  The 95% confidence intervals were relatively narrow using the “Rate 3” 
approach, followed by the “Count” approach.  The “Survival 1” and “Rate 1 & 2” 
approaches produced 95% confidence intervals of similar width in each circumstance.   
The remaining analysis approaches did not produce unbiased estimates of effect 
across the three exposure variables. 
 
Aim ii) The subset of analysis approaches that produced relatively unbiased effect 
estimates were then used in Generic Inverse Variance Measure MAL, the results of 
which (as opposed to their MAP results) are presented (figure 2).  Included in this 
figure also are the results from the modified “dichotomous data” MAL (Rate 5).  This 
figure demonstrates consistent incongruity between the MAP and MAL approaches 
for the gender and age exposure variables.  It is possible that this may be due to the 
higher levels of statistical heterogeneity across the three sites for these variables, as 
demonstrated by the higher I2 values.  Noticeable also for these two exposure 
variables were the considerably wider confidence intervals attained through the MAL 
analyses relative to their respective MAP.  None of the MAL analysis approaches 
were able to produce unbiased effect estimates across all three exposure variables in 
comparison to the MAP effect estimates generated through “Survival 1”, “Count”, and 
“Rate 1, 2 &3” approaches, though the degree of bias was not excessive.  The 
magnitude of effect was overstated in the MAL approaches for the gender and age 
exposure variables, and marginally understated for the stroke exposure variable.  
 
Aim iii)  The standard errors of the natural logarithm of the effect estimates generated 
through the analysis of individual site data for each exposure variable are presented 
(figure 3).  It is evident that the “Rate 3” approach produced consistently smaller 
standard errors of the natural logarithm of the rate ratio, and the bootstrap simulation 
approach the largest.  Hence, if combining data from any of these approaches into the 
one Generic Inverse Variance Method MAL, the results from the study employing the 
“Rate 3” approach will more heavily weighted, and those from the “Rate 1 & 2” 
bootstrap approach less heavily weighted, than if these studies had used the “Count” 





Meta-analysis is a tool that has frequently been demonstrated to provide valuable 
insights across a range of fields and has been recommended as a means of reducing 
bias.  However for the particular case of falls in hospitals, the utility of available 
meta-analysis instruments is less clear.  The nature of the outcome being count data 
and the inconsistency of follow-up duration in this setting as a natural consequence of 
patients’ varied length’s of stay in hospital complicates the pooling of data from 
separate studies.  This study has demonstrated that several analysis approaches are 
available that can produce relatively unbiased estimates of effect within an individual 
study.  Despite this, no currently available MAL approach was able to produce effect 
estimates that were congruent with those derived from MAP analyses.  This was 
particularly the case with greater levels of statistical heterogeneity within the data. 
 
Our initial research question confirmed the arguments put forward by previous 
authors that falls need to be modelled using approaches that treat them as events over 
time that may recur.15, 18, 19  It was clear from our data that dichotomising data into 
groupings of fallers versus non-fallers or multiple fallers versus non multiple fallers 
were poor surrogates for examining the rate of falls, even when adjusting for length of 
observation.   
 
Concerns previously raised that using a modified version of the relative risk formula 
produces variable results depending on the units that time is measured in were again 
confirmed.20  However, it should be noted that using the modified relative risk 
formula with time measured in days consistently produced relatively unbiased point 
estimates of the relative rate of falls.  This is notable as this is approach could be used 
in a MAL where individual studies have not presented an effect estimate but the 
relative number of falls and length of observation from exposed and unexposed 
groups can be gleaned.  The confidence intervals from this approach were 
considerably narrower than those gleaned from the “Survival 1” Andersen-Gill 
recurrent events, “Count” negative binomial regression and “Rate 1 & 2” bootstrap 
approaches indicating that use of these confidence intervals in a MAL could lead to 
spurious significant findings.  This is not surprising as the application of the relative 
risk formula to this data in no way permits acknowledgement of the dependence of 
falls or time data within individual patients.   
 
The bootstrap simulation approaches in contrast did produce conservative (possibly 
overly-conservative) 95% confidence intervals and unbiased effect point estimates, 
and were not affected by whether time data were measured in units of days or years.   
It was also notable that the bootstrap simulation approaches, which directly model the 
ratio of rate of falls between groups over the length of the study, produced point 
estimates of effect more consistent with the “Survival 1” Andersen-Gill approach than 
with the “Count” negative binomial regression approach, though the differences 
between these approaches was relatively small.  The disadvantage of this approach 
relative to the “Rate 3” modified relative risk calculation is that it cannot be executed 
without full access to individual patient level data.    
 
Contrasting the MAP and MAL findings where data has been analysed using a 
uniform approach demonstrated that pooled effect estimates using the MAL approach 
produced either biased or imprecise effect estimates relative to the MAP findings 
where statistical heterogeneity between study results was observed.  This raises the 
spectre of misleading pooled results from a MAL in such circumstances.  If different 
analysis approaches have been used, pooling of hazard ratios derived from Andersen-
Gill analyses and Incidence Rate Ratios derived from negative binomial regression 
appears reasonable given their proximity of effect point estimates and comparable 
standard errors.  Including data from bootstrap analysis or modified relative risk 
calculations (where time is measured in days) will under or over influence the pooled 
effect estimate due to the relative size of their standard errors, though could always be 
acknowledged in the discussion and considered by readers if the number of studies 
contributing data in this way was very small.  
 
For a researcher seeking to conduct a meta-analysis in the field of falls prevention in 
the hospital setting, several factors need to be considered.  A MAL may produce 
unbiased and precise effect estimates if there is no heterogeneity in study findings and 
the effect estimates in individual studies have been presented using Andersen-Gill 
survival analysis (or other recurrent events survival analysis approaches demonstrated 
to produce equivalent results18), negative binomial regression, or bootstrap simulation 
approaches to calculation of a relative rate.  Inclusion of data from a relative rate 
derived through modification of the relative risk formula (where time is measured in 
days) may also be considered, though is likely to overly influence the pooled effect 
point estimate and produce confidence intervals that are too narrow.  In this field, 
heterogeneity in study results, even amongst the small number of large randomised 
trials to date, is likely.10, 11, 21, 22  This study also demonstrated statistical heterogeneity 
in MAL of two out of three risk factors considered.   
 
Given the likely difficulty in attaining individual patient level data in this field, a 
researcher seeking to conduct a meta-analysis has limited options.  We would suggest 
systematic review and presentation of individual results rather than seeking to 
calculate a pooled effect estimate.  This would also negate other serious concerns such 
as pooling data from interventions that by their content are heterogenous, from risk 
factors where exposure has been measured inconsistently, and studies that have used 
varying patient populations.  Meta-analysis can provide profound insight into a 
research field, however, in our opinion, should only be conducted when the results are 
expected to provide greater clarity than what is already afforded by individual study 
results.  Heterogeneity of all forms, and difficulties in using a MAL approach that can 
produce a precise and unbiased pooled effect estimate are serious concerns that all 
authors, reviewers, and readers need to give greater attention to when considering 
results of a meta-analysis where the outcome of interest is a recurrent event.   
 
This study had several limitations, principally, the number of factors and number of 
studies considered was small.  Greater subtlety in strengths and limitations of the 
MAL approaches investigated could be revealed by examining a greater number and 
combinations of factors (eg.e.g. nNumber of studies, size of studies, strength of effect, 
statistical heterogeneity between studies) that may impact upon its accuracy.  Other 
forms of recurrent events data will have data distributions different to those of the 
falls dataset examined in the present study warranting replication of this study with 
other clinical data distribution examples to determine consistency of results with the 
present study.  There were also other approaches for analysis of recurrent events data 
(eg. Conditional survival analysis models) that were not investigated in the present 
study that could also be the focus of further investigation.
Table 1.  Description and justification of analysis approaches used to address aim i). 
 
Treatment of falls 
data 
Description Justification 
Survival; time to 
event data (1) 
Andersen-Gill survival analysis for recurrent events, using robust 
variance estimates to account for dependency of events within an 
individual. Effect estimate referred to as Hazard Ratio. 
Recognised by previous authors as an appropriate 
approach for analysing recurrent event and 
specifically falls rate data.14, 15, 18, 19 
Survival; time to 
event data (2) 
Cox semi-parametric survival analysis, time until first event 
(ignores participant data after the first event). Effect estimate 
referred to as Hazard Ratio. 
Time to first event analysis approach previously 




Negative binomial regression, a form of Poisson regression for 
overdispersed count data (where the outcome mean is exceeded by 
the standard deviation).  Adjusting for individual participant 
period of observation in the study effectively makes this a 
comparison of rate data. Effect estimate referred to as Incidence 
Recognised by previous authors as an appropriate 
standard for analysing falls rate data.15, 18, 19 
Rate Ratio. 
Rate data (1) Bootstrap simulation for calculation of a rate ratio and normal-
based 95% confidence intervals. Rate ratio calculated as (total falls 
in exposed group / total time in exposed group) / (total falls in 
unexposed group / total time in unexposed group).  Time 
measured in days. 
Has been used to calculate confidence intervals in 
evaluations of falls risk screening tools and falls 
risk factors in the hospital setting.9, 23, 24 
Rate data (2) As above however time measured in years. The Cochrane Collaboration raises concern that 
changing the units that time is measured in 
changes the results.17 
Rate data (3) Calculation of a relative rate using the formula for relative risk 
whereby the number of falls in exposed / unexposed groups 
substitutes for the number of participants with the disease in these 
groups, and the amount of observed participant time in exposed / 
unexposed groups substitutes for the number of participants 
without the disease in these groups.  Time measured in days. 
Previously used to evaluate the effectiveness of a 
multi-factorial intervention program to reduce 
falls in this setting.10 
Rate data (4) As above however time measured in years. It has previously been demonstrated that 
changing the units that time is measured in 
changes the results when relative rate is 
calculated in this way.20 
Binary data (1) Logistic regression classifying all patients experiencing one or 
more falls as a faller as opposed to being a non-faller. Effect 
estimate referred to as Odds Ratio. 
Frequently presented data in epidemiologic and 
experimental studies in this setting. An analysis 
option forwarded by the Cochrane Collaboration 
for considering count data where a minority of 
participants have the event and the counts for 
those who do are mostly low.17 
Binary data (2) As above however including adjustment for participant period of 
observation in the study. 
Adjusting for participant exposure may 
compensate for insensitivity of the analysis 
approach above to variation in patient length of 
stay in hospital. 
Binary data (3) Logistic regression classifying all patients experiencing two or Frequently presented data in falls prevention 
more falls as a multiple faller as opposed to being a non-multiple 
faller. 
studies more broadly. 
Binary data (4) As above however including adjustment for participant period of 
observation in the study. 
Adjusting for participant exposure may 
compensate for insensitivity of the analysis 
approach above to variation in patient length of 
stay in hospital. 
Binary data (5) Relative risk analysis classifying all patients experiencing one or 
more falls as a faller as opposed to being a non-faller. Effect 
presented as Relative Risk.32 
Previously used to evaluate the effectiveness of a 
multi-factorial intervention program to reduce 
falls in this setting.11 
 
 
Table 2. Distribution of exposure, outcome and participant observation variables for the combined dataset and each site. 
 
 Complete dataset Melbourne Brisbane Perth 
n 1828 626 852 350 
Gender; male – n (%) 767 (42%) 206 (33%) 426 (50%) 135 (39%) 
Age – mean (sd) 76.7 (10.7) 79.8 (9.3) 73.2 (11.4) 79.5 (8.5) 
Admission diagnosis stroke – n (%) 170 (9%) 72 (12%) 65 (8%) 33 (9%) 
Falls; total 497 254 177 66 
Fallers; 1 or more falls – n (%) 275 (15%) 125 (20%) 105 (12%) 45 (13%) 
Multi-fallers; 2 or more falls – n (%) 89 (5%) 41 (7%) 34 (4%) 14 (4%) 
Length of observation; mean (sd) per patient 25.6 (26.2) 29.7 (22.2) 26.0 (30.7) 17.2 (18.0) 
 
Figure 1.  MAP pooled effect estimates with 95% CIs utilising each analysis approach described for each exposure variable.  Effect estimates >1 














Figure 2.  MAP versus MAL pooled effect estimates (95% CIs), and I2 values (for MAL analyses) for each exposure variable.  Effect estimates 
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